TickerFacts.

Emergent BioSolutions Inc. (EBS) — Operating Cash Flow

Annual figures by period end, from SEC filings.

2009-12-31: $29.87M2010-12-31: $98.02M2011-12-31: $12.19M2012-12-31: $39.64M2013-12-31: $96.97M2014-12-31: $112.32M2015-12-31: $42.52M2016-12-31: $54.60M2017-12-31: $208.10M2018-12-31: $41.80M2019-12-31: $188.00M2020-12-31: $536.90M2021-12-31: $320.20M2022-12-31: -$34.10M2023-12-31: -$206.30M2024-12-31: $58.70M2025-12-31: $170.60M$170.60M
2009-12-31Operating Cash Flow (USD)2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31$170.60M+190.6%2026-02-27From 2025-01-01
2024-12-31$58.70M—2026-02-27From 2024-01-01
2023-12-31-$206.30M—2026-02-27From 2023-01-01
2022-12-31-$34.10M-110.6%2025-03-04From 2022-01-01
2021-12-31$320.20M-40.4%2024-03-08From 2021-01-01
2020-12-31$536.90M+185.6%2023-12-11From 2020-01-01
2019-12-31$188.00M+349.8%2022-02-25From 2019-01-01
2018-12-31$41.80M-79.9%2021-02-19From 2018-01-01
2017-12-31$208.10M+281.1%2020-02-25From 2017-01-01
2016-12-31$54.60M+28.4%2019-02-22From 2016-01-01
2015-12-31$42.52M-62.1%2018-02-23From 2015-01-01
2014-12-31$112.32M+15.8%2015-03-09From 2014-01-01
2013-12-31$96.97M+144.6%2015-03-09From 2013-01-01
2012-12-31$39.64M+225.3%2015-03-09From 2012-01-01
2011-12-31$12.19M-87.6%2014-03-10From 2011-01-01
2010-12-31$98.02M+228.2%2013-03-08From 2010-01-01
2009-12-31$29.87M—2012-03-09From 2009-01-01